Search / Trial NCT06612294

Asthma Symptom Perception Study

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Sep 23, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

The Asthma Symptom Perception Study is researching how older adults with asthma can better recognize when their breathing is affected. This is important because many older adults are not aware of their breathing difficulties, which can lead to worse asthma control and more hospital visits. The study aims to help participants learn to notice and understand their breathing patterns through a training program combined with motivational support. They will involve 300 adults aged 60 and older who struggle to manage their asthma and are receiving treatment.

To be eligible for this study, participants need to be over 60 years old, speak either English or Spanish, and have been diagnosed with asthma for more than a year. They must also be experiencing uncontrolled asthma symptoms. During the study, participants will attend three sessions over six weeks, where they will receive either the training or a general educational program. Researchers will check how well the training works by looking at changes in lung function, asthma control, and overall quality of life at different points over the next year. This study is crucial for finding better ways to help older adults manage their asthma effectively.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \> 60 years
  • English or Spanish speaking
  • Self-report or physician diagnosis of asthma \>1 year ago
  • Uncontrolled asthma
  • Exclusion Criteria:
  • Dementia
  • Chronic obstructive pulmonary disease (COPD), or other chronic respiratory illnesses,
  • Congestive Heart Failure (CHF, New York Heart Association \[NYHA\] stages 4-5)
  • Cigarette smoking \>15 packs-years

Trial Officials

Juan Wisnivesky, MD, DrPH

Principal Investigator

Division Chief, General Internal Medicine

About Icahn School Of Medicine At Mount Sinai

The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.

Locations

Bronx, New York, United States

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0